Medications starting with

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia or lymphoblastic blast crisis in adults and children (from 1 year of age) for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Lek Pharmaceuticals d.d. Remedica Ltd

Dasatinib Stada is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used for the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and for the treatment of acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicinal product is used for the treatment of chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and for the treatment of acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment has been ineffective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, and for the treatment of acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (Ph+) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment was ineffective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

The medicine is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children aged 1 year and older, and for the treatment of acute lymphoblastic leukemia (ALL) with the presence of the Philadelphia chromosome (Ph+) in adults, adolescents, and children (from 1 year of age), as well as in the lymphoblastic blast crisis of CML in adults for whom previous treatment was ineffective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Centrafarm Services B.V. Remedica Ltd STADA Arzneimittel AG

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age), as well as to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age), and in a specific form of myeloid leukemia in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used in the treatment of blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

It is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It helps to inhibit the growth of leukemia cells.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used in the treatment of lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used to treat the blast crisis phase of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

This medicine is used in adults, adolescents, and children (over 1 year of age) for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It is also used to treat the lymphoblastic blast crisis of chronic myeloid leukemia in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.

The medicine is used for the treatment of acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age. It is also used in adults for the lymphoblastoid blast crisis of CML, if previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used for the treatment of acute lymphoblastic leukaemia (ALL) in adults, adolescents and children over 1 year of age, and for the treatment of chronic myeloid leukaemia (CML) in adults, adolescents and children over 1 year of age, as well as in the lymphoblastoid blast crisis of CML in adults.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age. It is also used in adults for the lymphoblastoid blast crisis of CML if previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used for the treatment of acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastoid blast crisis of CML in adults.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML) in adults, adolescents, and children aged 1 year and older. It inhibits the growth of cancer cells.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat acute lymphoblastic leukemia (ALL) in adults, adolescents, and children over 1 year of age, and to treat chronic myeloid leukemia (CML) in adults, adolescents, and children over 1 year of age, as well as in the lymphoblastoid blast crisis of CML in adults.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia in whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age) and to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children (from 1 year of age), as well as in the lymphoblastic blast crisis of myeloid leukemia in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to treat chronic myeloid leukemia in adults, adolescents, and children (from 1 year of age), as well as to treat acute lymphoblastic leukemia in adults, adolescents, and children (from 1 year of age), and in the lymphoblastic blast crisis in adults for whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia, in whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat chronic myeloid leukemia in adults, adolescents and children (from 1 year of age) and to treat acute lymphoblastic leukemia in adults, adolescents and children (from 1 year of age). It is also used in adults for the lymphoblastic blast crisis of chronic myeloid leukemia, in whom previous treatment has not been effective.

Dosage form: tablets, film-coated

ATC code: L01EA02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used to relieve the symptoms of allergic rhinitis (such as sneezing, itching or a runny nose, itchy palate, and watery and red eyes) and the symptoms of urticaria (itching and skin lesions).

Dosage form: tablets, film-coated

ATC code: R06AX27

Manufacturer: Krka, d.d., Novo mesto

The medicinal product is used in infections of the upper respiratory tract (e.g., pharyngitis, sinusitis), lower respiratory tract (e.g., pneumonia, bronchitis), skin and soft tissues (e.g., abscesses, boils), the gastrointestinal tract, as well as in dentistry (e.g., gingivitis) and in the case of scarlet fever.

Dosage form: tablets, film-coated

ATC code: J01FA01

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

The medicinal product is used for the topical treatment of acne vulgaris.

Dosage form: solution, topical

ATC code: D10AF02

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

Davercin is used to treat various bacterial infections, such as respiratory tract infections (e.g., pneumonia), pertussis in children, urethritis, gastrointestinal infections, pityriasis rosea, chancroid, and certain skin and soft tissue infections.

Dosage form: powder for preparation of oral suspension

ATC code: J01FA01

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

The medicinal product is used for the topical treatment of acne vulgaris.

Dosage form: gel

ATC code: D10AF02

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

It is used for the topical treatment of acne vulgaris.

Dosage form: gel

ATC code: D10AF02

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

It is used in men with mild enlargement of the prostate gland (benign prostatic hyperplasia). It helps relieve urinary problems, such as a weak stream or frequent bathroom visits, and reduces the risk of needing surgery.

Dosage form: capsules, soft gelatin

ATC code: G04CB02

Manufacturer: Laboratorios León Farma, S.A.

The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins and lungs. In children, it is used to treat blood clots and to prevent their recurrence.

Dosage form: capsules, hard

ATC code: B01AE07

Manufacturer: Krka d.d., Novo mesto

Daxanlo is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of recurrence of blood clots in the leg and lung veins. In children, it is used for the treatment and prevention of recurrence of blood clots.

Dosage form: capsules, hard

ATC code: B01AE07

Manufacturer: Krka d.d., Novo mesto

In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, this medicine is used to treat blood clots and to prevent their recurrence.

Dosage form: capsules, hard

ATC code: B01AE07

Manufacturer: Krka d.d., Novo mesto

This is a contraceptive tablet used to prevent pregnancy.

Dosage form: tablets, film-coated

ATC code: G03AA12

Manufacturer: Gedeon Richter Plc.

This is a contraceptive tablet used to prevent pregnancy.

Dosage form: tablets, film-coated

ATC code: G03AA12

Manufacturer: Gedeon Richter Plc.

This is a contraceptive tablet used to prevent pregnancy.

Dosage form: tablets, film-coated

ATC code: G03AA12

Manufacturer: Gedeon Richter Plc.

This is an antibiotic used in the treatment of upper respiratory tract infections caused by sensitive streptococci and in the treatment of syphilis. In adults, it is also used to prevent recurrences of rheumatic fever, endocarditis, and glomerulonephritis, whereas in children, it is used exclusively for the prevention of rheumatic disease and endocarditis.

Dosage form: powder for preparation of injection suspension

ATC code: J01CE08

Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

The medicinal product is used in the treatment of irritable bowel syndrome and other functional gastrointestinal disorders, such as diarrhea, constipation, abdominal pain, or intestinal spasms.

Dosage form: tablets, film-coated

ATC code: A03AA05

Manufacturer: Pharmaceutical Plants POLPHARMA S.A. Sieradz Branch Medana and New Deba Production Branch

The medicine is used in adults to relieve symptoms of irritable bowel syndrome, intestinal complaints associated with functional gastrointestinal disorders, and pain associated with functional disorders of the gastrointestinal tract and biliary tract.

Dosage form: tablets, film-coated

ATC code: A03AA05

Manufacturer: POLPHARMA S.A. Pharmaceutical Works POLPHARMA S.A. Production Branch in Nowa Dęba

The medicine is used in adults for the symptomatic treatment of irritable bowel syndrome, intestinal complaints associated with functional gastrointestinal disorders, and pain associated with functional gastrointestinal and biliary tract disorders.

Dosage form: tablets, film-coated

ATC code: A03AA05

Manufacturer: POLPHARMA S.A. Pharmaceutical Works POLPHARMA S.A. Production Branch in Nowa Dęba

The medicine is used to relieve intestinal disorders and pain associated with functional disorders of the gastrointestinal tract and bile ducts.

Dosage form: tablets, film-coated

ATC code: A03AA05

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to relieve pain associated with functional disorders of the gastrointestinal tract and bile ducts, and to correct motility disorders and intestinal complaints.

Dosage form: powder for preparation of oral suspension

ATC code: A03AA05

Manufacturer: Pfizer Europe MA EEIG

The medicine is used to relieve intestinal dysfunction and pain associated with functional disorders of the gastrointestinal tract and bile ducts.

Dosage form: tablets, film-coated

ATC code: A03AA05

Manufacturer: Pfizer Europe MA EEIG

It is used in the treatment of osteoporosis and as an adjunct in disease states characterized by a negative nitrogen balance.

Dosage form: solution for injection

ATC code: A14AB01

Manufacturer: Aspen Pharma Trading Limited

The medicine is used to treat osteoporosis (loss of bone tissue) and as an adjunct therapy in disease states characterized by a negative nitrogen balance.

Dosage form: solution for injection

ATC code: A14AB01

Manufacturer: Aspen Pharma Trading Limited

It is used in the treatment of osteoporosis and as an adjunct in disease states characterized by a negative nitrogen balance.

Dosage form: solution for injection

ATC code: A14AB01

Manufacturer: Aspen Pharma Trading Limited

The medicine is used in the treatment of osteoporosis (loss of bone tissue) and as an adjunct in disease states characterized by a negative nitrogen balance.

Dosage form: solution for injection

ATC code: A14AB01

Manufacturer: Aspen Pharma Trading Limited

The medicine is used in adults to treat diseases that affect thinking, feeling, and behavior, such as schizophrenia. It helps in cases of, among others, hallucinations, delusions, paranoia, aggression, or feelings of confusion.

Dosage form: solution for injection

ATC code: N05AD01

Manufacturer: Polpharma Pharmaceutical Works S.A.

In men, it is used for the treatment of hormone-dependent prostate cancer (locally advanced or metastatic), whereas in women, it is used for the treatment of endometriosis.

Dosage form: solution for injection

ATC code: L02AE04

Manufacturer: Ferring GmbH